Current Advances in Lung Cancer Diagnosis and Treatment

Dear Colleagues,

Remarkable advances in systemic agents, such as targeted therapies and immuno-oncological agents, are significantly changing the treatment methods for lung cancer patients based on the stage they are in.

In particular, this enables more aggressive local therapy in the treatment of stage IV lung cancer. The current National Comprehensive Cancer Network guidelines also recommend consolidative local therapy for selected patients with localized metastatic lung cancer who have responded to prior chemotherapy and have a limited extra-thoracic tumor burden. However, in actual clinical settings, there are still no consistent treatment principles for defining criteria for localized metastasis, as well as for evaluating and treating oligo-progression. In active local treatment, it is important to consider the patient's general condition, such as the presence of any underlying lung disease and the potential side effects of the treatment.

In this Special Issue, we will compile studies related to improving clinical outcomes or predicting side effects, aligned with the latest knowledge on lung cancer treatment.

Dr. Hakyoung Kim
Dr. Daesik Yang
Dr. Zhiwei Hu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.